|
1
|
Maynard SE, Min JY, Merchan J, Lim KH, Li
J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et
al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may
contribute to endothelial dysfunction, hypertension, and
proteinuria in preeclampsia. J Clin Invest. 111:649–658. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Caniggia I, Mostachfi H, Winter J,
Gassmann M, Lye SJ, Kuliszewski M and Post M: Hypoxia-inducible
factor-1 mediates the biological effects of oxygen on human
trophoblast differentiation through TGFbeta(3). J Clin Invest.
105:577–587. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allaire AD, Ballenger KA, Wells SR,
McMahon MJ and Lessey BA: Placental apoptosis in preeclampsia.
Obstet Gynecol. 96:271–276. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI
|
|
5
|
Rácz Z, Kaucsár T and Hamar P: The huge
world of small RNAs: Regulating networks of microRNAs (review).
Acta Physiol Hung. 98:243–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schober A, Nazari-Jahantigh M, Wei Y,
Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H,
Hristov M, et al: MicroRNA-126-5p promotes endothelial
proliferation and limits atherosclerosis by suppressing Dlk1. Nat
Med. 20:368–376. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murphy MS, Casselman RC, Tayade C and
Smith GN: Differential expression of plasma microRNA in
preeclamptic patients at delivery and 1 year postpartum. Am J
Obstet Gynecol. 213:367.e1–e9. 2015. View Article : Google Scholar
|
|
9
|
Akehurst C, Small HY, Sharafetdinova L,
Forrest R, Beattie W, Brown CE, Robinson SW, McClure JD, Work LM,
Carty DM, et al: Differential expression of microRNA-206 and its
target genes in preeclampsia. J Hypertens. 33:2068–2074. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Enquobahrie DA, Abetew DF, Sorensen TK,
Willoughby D, Chidambaram K and Williams MA: Placental microRNA
expression in pregnancies complicated by preeclampsia. Am J Obstet
Gynecol. 204:178.e12–e21. 2011. View Article : Google Scholar
|
|
11
|
Dar AA, Majid S, Rittsteuer C, de Semir D,
Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR III and
Kashani-Sabet M: The role of miR-18b in MDM2-p53 pathway signaling
and melanoma progression. J Natl Cancer Inst. 105:433–442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshimoto N, Toyama T, Takahashi S,
Sugiura H, Endo Y, Iwasa M, Fujii Y and Yamashita H: Distinct
expressions of microRNAs that directly target estrogen receptor α
in human breast cancer. Breast Cancer Res Treat. 130:331–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu X, Zhen Y, Yang H, Wang H, Zhou Y, Wang
E, Marincola FM, Mai C, Chen Y, Wei H, et al: Loss of connective
tissue growth factor as an unfavorable prognosis factor activates
miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in
nasopharyngeal carcinoma. Cell Death Dis. 4:e6342013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang C, Li Q, Ren N, Li C, Wang X, Xie M,
Gao Z, Pan Z, Zhao C, Ren C and Yang W: Placental miR~106a-363
cluster is dysregulated in preeclamptic placenta. Placenta.
36:250–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Semenza G: Signal transduction to
hypoxia-inducible factor 1. Biochem Pharmacol. 64:993–998. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Semenza GL: HIF-1, O(2), and the 3 PHDs:
How animal cells signal hypoxia to the nucleus. Cell. 107:1–3.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Taylor CT: Mitochondria and cellular
oxygen sensing in the HIF pathway. Biochem J. 409:19–26. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ietta F, Wu Y, Winter J, Xu J, Wang J,
Post M and Caniggia I: Dynamic HIF1A regulation during human
placental development. Biol Reprod. 75:112–121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom
J, Many A, Zamudio S and Caniggia I: Increased expression of sFlt-1
in in vivo and in vitro models of human placental hypoxia is
mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol.
291:R1085–R1093. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aplin JD: Hypoxia and human placental
development. J Clin Invest. 105:559–560. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goldman-Wohl D and Yagel S: Preeclampsia-a
placenta developmental biology perspective. J Reprod Immunol.
82:96–99. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shah DM: Preeclampsia: New insights. Curr
Opin Nephrol Hypertens. 16:213–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Granger JP, Alexander BT, Llinas MT,
Bennett WA and Khalil RA: Pathophysiology of preeclampsia: Linking
placental ischemia/hypoxia with microvascular dysfunction.
Microcirculation. 9:147–160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang
YJ, Zhao L, Chen FH, Wang XT, You QD and Guo QL: HIF-1α is critical
for hypoxia-mediated maintenance of glioblastoma stem cells by
activating Notch signaling pathway. Cell Death Differ. 19:284–294.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang LE, Gu J, Schau M and Bunn HF:
Regulation of hypoxia-inducible factor 1alpha is mediated by an
O2-dependent degradation domain via the ubiquitin-proteasome
pathway. Proc Natl Acad Sci USA. 95:7987–7992. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ivan M, Kondo K, Yang H, Kim W, Valiando
J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr: HIFalpha
targeted for VHL-mediated destruction by proline hydroxylation:
Implications for O2 sensing. Science. 292:464–468. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weidemann A and Johnson RS: Biology of
HIF-1alpha. Cell Death Differ. 15:621–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wenger RH, Stiehl DP and Camenisch G:
Integration of oxygen signaling at the consensus HRE. Sci STKE.
2005:re122005.PubMed/NCBI
|
|
33
|
Jung JE, Lee HG, Cho IH, Chung DH, Yoon
SH, Yang YM, Lee JW, Choi S, Park JW, Ye SK and Chung MH: STAT3 is
a potential modulator of HIF-1-mediated VEGF expression in human
renal carcinoma cells. FASEB J. 19:1296–1298. 2005.PubMed/NCBI
|
|
34
|
Liu W, Shen SM, Zhao XY and Chen GQ:
Targeted genes and interacting proteins of hypoxia inducible
factor-1. Int J Biochem Mol Biol. 3:165–178. 2012.PubMed/NCBI
|
|
35
|
Williams PJ and Pipkin Broughton F: The
genetics of pre-eclampsia and other hypertensive disorders of
pregnancy. Best Pract Res Clin Obstet Gynaecol. 25:405–417. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pineles BL, Romero R, Montenegro D, Tarca
AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P,
et al: Distinct subsets of microRNAs are expressed differentially
in the human placentas of patients with preeclampsia. Am J Obstet
Gynecol. 196:261.e1–e6. 2007. View Article : Google Scholar
|
|
37
|
Zhu XM, Han T, Sargent IL, Yin GW and Yao
YQ: Differential expression profile of microRNAs in human placentas
from preeclamptic pregnancies vs normal pregnancies. Am J Obstet
Gynecol. 200:661.e1–e7. 2009. View Article : Google Scholar
|
|
38
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sand M, Skrygan M, Sand D, Georgas D, Hahn
SA, Gambichler T, Altmeyer P and Bechara FG: Expression of
microRNAs in basal cell carcinoma. Br J Dermatol. 167:847–855.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Harris LK: Review: Trophoblast-vascular
cell interactions in early pregnancy: how to remodel a vessel.
Placenta. 31 Suppl:93–98. 2010. View Article : Google Scholar
|
|
42
|
Graham CH, Hawley TS, Hawley RG,
MacDougall JR, Kerbel RS, Khoo N and Lala PK: Establishment and
characterization of first trimester human trophoblast cells
extended with lifespan. Exp Cell Res. 206:204–211. 1993. View Article : Google Scholar : PubMed/NCBI
|
